---
figid: PMC7187267__YEA-37-283-g006
figlink: pmc/articles/PMC7187267/figure/yea3461-fig-0006/
number: F6
caption: Nicotinic acid de novo synthesis and salvage pathway in Saccharomyces cerevisiae.
  NAD+ is de novo synthesized from L‐tryptophan in nine catalytic steps involving
  the Bna enzyme family and enzymes Nma1, Nma2, and Qns1. Nicotinic acid can be imported
  into the cell via Tna1 and enters the NAD synthesis pathway as NaMN by catalytic
  activity of Npt1. Similarly, NaR can be salvaged by catalytic activity of Nrk1 to
  form NaMN. NaR can be also converted to nicotinic acid by Urh1 and Pnp1. Nrk1 also
  converts NR into NMN subsequently converted to NAD+ by Nma1 and Nma2. NR is imported
  by activity of Nrt1 transporter and might be used by Pnp1 or Urh1 to form nicotinamide.
  Alternatively, nicotinamide can be synthesized via Sir2 from NAD+. Pnc1 uses nicotinamide
  to form nicotinic acid. The regulators Hst1 (with aid of Rfm1 and Sum1) and Mac1
  repress the expression of genes encoding Bna enzymes upon binding to NAD+ and nicotinic
  acid. Metabolites, proteins and negative regulators are shown in bold, blue and
  red respectively. NAD+, nicotinamide adenine dinucleotide; NaMN, nicotinic acid
  mononucleotide; NAR, nicotinamide riboside; NMN, nicotinamide nucleotide; NR, nicotinamide
  riboside [Colour figure can be viewed at http://wileyonlinelibrary.com]
pmcid: PMC7187267
papertitle: Vitamin requirements and biosynthesis in Saccharomyces cerevisiae .
reftext: Thomas Perli, et al. Yeast. 2020 Apr;37(4):283-304.
pmc_ranked_result_index: '53062'
pathway_score: 0.9334164
filename: YEA-37-283-g006.jpg
figtitle: Nicotinic acid de novo synthesis and salvage pathway in Saccharomyces cerevisiae
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7187267__YEA-37-283-g006.html
  '@type': Dataset
  description: Nicotinic acid de novo synthesis and salvage pathway in Saccharomyces
    cerevisiae. NAD+ is de novo synthesized from L‐tryptophan in nine catalytic steps
    involving the Bna enzyme family and enzymes Nma1, Nma2, and Qns1. Nicotinic acid
    can be imported into the cell via Tna1 and enters the NAD synthesis pathway as
    NaMN by catalytic activity of Npt1. Similarly, NaR can be salvaged by catalytic
    activity of Nrk1 to form NaMN. NaR can be also converted to nicotinic acid by
    Urh1 and Pnp1. Nrk1 also converts NR into NMN subsequently converted to NAD+ by
    Nma1 and Nma2. NR is imported by activity of Nrt1 transporter and might be used
    by Pnp1 or Urh1 to form nicotinamide. Alternatively, nicotinamide can be synthesized
    via Sir2 from NAD+. Pnc1 uses nicotinamide to form nicotinic acid. The regulators
    Hst1 (with aid of Rfm1 and Sum1) and Mac1 repress the expression of genes encoding
    Bna enzymes upon binding to NAD+ and nicotinic acid. Metabolites, proteins and
    negative regulators are shown in bold, blue and red respectively. NAD+, nicotinamide
    adenine dinucleotide; NaMN, nicotinic acid mononucleotide; NAR, nicotinamide riboside;
    NMN, nicotinamide nucleotide; NR, nicotinamide riboside [Colour figure can be
    viewed at http://wileyonlinelibrary.com]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CPSF4
  - NMRK1
  - SLC17A1
  - SLC25A33
  - MFAP1
  - PNMA1
  - IGSF9
  - L-tryptophan
  - L-formylkynurenine
  - kynurenine
  - NADPH
  - O
  - NADP
  - H
  - 3-hydroxy-L-kynurenine
  - 3-hydroxy-anthranilate
  - 2-amino-3-carboxymuconate
  - semialdehyde
  - quinolinic acid
  - nicotinic acid
  - NaMN
  - L-glutamine
  - ATP
  - glutamate
  - PP
  - AMP
  - NAD
  - nicotinamide
genes:
- word: NaR
  symbol: NAR
  source: hgnc_alias_symbol
  hgnc_symbol: CPSF4
  entrez: '10898'
- word: Nrk1
  symbol: NRK1
  source: hgnc_alias_symbol
  hgnc_symbol: NMRK1
  entrez: '54981'
- word: Npt1
  symbol: NPT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC17A1
  entrez: '6568'
- word: Pnc1
  symbol: PNC1
  source: hgnc_alias_symbol
  hgnc_symbol: SLC25A33
  entrez: '84275'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: L-glutamate,PP,AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: Мaс1
  symbol: MA1
  source: hgnc_alias_symbol
  hgnc_symbol: PNMA1
  entrez: '9240'
- word: Nrt1
  symbol: Nrt1
  source: hgnc_alias_symbol
  hgnc_symbol: IGSF9
  entrez: '57549'
- word: Nrk1
  symbol: NRK1
  source: hgnc_alias_symbol
  hgnc_symbol: NMRK1
  entrez: '54981'
chemicals:
- word: L-tryptophan
  source: ''
  identifier: ''
- word: L-formylkynurenine
  source: MESH
  identifier: C036915
- word: kynurenine
  source: MESH
  identifier: C029366
- word: NADPH
  source: MESH
  identifier: D009249
- word: O
  source: MESH
  identifier: D013481
- word: NADP
  source: MESH
  identifier: D009249
- word: H
  source: MESH
  identifier: D006859
- word: 3-hydroxy-L-kynurenine
  source: ''
  identifier: ''
- word: 3-hydroxy-anthranilate
  source: MESH
  identifier: C031385
- word: 2-amino-3-carboxymuconate
  source: MESH
  identifier: C558759
- word: semialdehyde
  source: MESH
  identifier: C009338
- word: quinolinic acid
  source: MESH
  identifier: D017378
- word: nicotinic acid
  source: MESH
  identifier: D009539
- word: NaMN
  source: MESH
  identifier: D012964
- word: L-glutamine
  source: ''
  identifier: ''
- word: ATP
  source: MESH
  identifier: D000255
- word: glutamate
  source: ''
  identifier: ''
- word: PP
  source: MESH
  identifier: C466065
- word: AMP
  source: MESH
  identifier: D000249
- word: NAD
  source: MESH
  identifier: D009243
- word: nicotinamide
  source: MESH
  identifier: D009536
diseases: []
figid_alias: PMC7187267__F6
redirect_from: /figures/PMC7187267__F6
figtype: Figure
---
